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ABSTRACT
Objectives: Type 2 diabetes mellitus (T2DM) is a metabolic disorder usually characterized by hyperglycemia. Adipose tissue secretes bioactive 
substances known as adipocytokines including leptin, tumor necrosis factor-alpha (TNF-α), and adiponectin. These are considered as a bridge 
connecting obesity and insulin resistance. There is considerable epidemiological evidence to suggest a role of Vitamin D deficiency in the etiology of 
T2DM. This study was performed to evaluate and compare serum Vitamin D and adipocytokine levels in T2DM patients and healthy controls of Jammu 
and Kashmir region of India.
Methods: A total of 200 T2DM patients and normal 200 healthy controls were considered for the study. Enzyme-linked immunosorbent assay was 
used to measure serum leptin and TNF-α levels. The Vitamin D levels were measured by chemiluminescent microparticle immunoassay method. 
Biochemical parameters were measured by the enzymatic method.
Results: Our results concluded that basic metabolic parameters, TNF-α and leptin levels were significantly higher in cases than controls. The serum 
Vitamin D levels were found significantly lower among T2DM patients. No correlation of Vitamin D with leptin was observed in cases and controls. 
However, a positive correlation between leptin and TNF-α was noted in T2DM subjects as well as in controls with statistical significance being higher 
in females (r=0.500; p=0.001) as compared to males (r=0.298; p=0.036) in T2DM subjects as well as in controls (r=0.659; p=0.001; r=0.621; p=001).
Conclusion: These results concluded that lowering of Vitamin D levels and upregulation of leptin and TNF-α altogether play an important role in the 
development of T2DM, and from correlation analysis, it could be predicted that leptin and TNF-α act in a synergistic manner toward the development 
of T2DM.
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INTRODUCTION
Diabetes mellitus is a group of metabolic diseases characterized by 
hyperglycemia resulting due to insulin insufficiency, diminished insulin 
action, or both. It is a serious public health problem in developed as well as 
developing countries [1]. Adipose tissue secretes bioactive peptides which 
are functionally similar to cytokines and are known as adipocytokines. 
These include leptin, tumor necrosis factor-alpha (TNF-α), interleukin-6 
(IL-6), adiponectin, and resistin. These adipocytokines control glucose and 
fatty acid metabolism [2] and also influence the activity of other tissues [3].
TNF-α is a cytokine which regulates cellular as well as biological 
processes and has been linked to cancer, lung cardiovascular diseases, 
and T2DM [4]. It has been documented to alter insulin sensitivity 
by triggering several key steps in the insulin signaling pathway [5] 
and effects glucose metabolism [6,7]. It also plays a key role in the 
pathogenesis of obesity-induced insulin resistance and T2DM [8,9].
Leptin is an adipocyte-secreted hormone/cytokine which regulates 
energy expenditure, behavior, and glucose metabolism to maintain 
body fat stores [10,11]. It plays a role in reducing insulin secretion 
from pancreatic β-cells and inhibits insulin biosynthesis by decreasing 
preproinsulin mRNA expression in β-cells. Further, leptin therapy 
in lipodystrophic patients was shown to improve insulin-stimulated 
hepatic and peripheral glucose metabolism [12].
Vitamin D is a vital factor for physiological functioning of skeletal as 
well as non-skeletal tissues where its deficiency can lead to disorders in 
both the tissues [13,14]. It has both direct and indirect effects on insulin 
secretion, β-cell function, and insulin resistance [15,16]. Several studies 
have demonstrated a link between Vitamin D deficiency and incidence 
of T2DM. Recently, Vitamin D receptor gene polymorphism and its 
association with T2DM has also been demonstrated [17]. Some studies 
have indicated that lower levels of Vitamin D are associated with higher 
serum levels of inflammatory biomarkers, such as IL-6, TNF-α, and 
C-reactive protein in healthy [18-21] and obese subjects [22] while 
others could not confirm these findings [23-26].
METHODS
The study was carried on 200 T2DM patients (30–70 years) who were 
diagnosed according to the current ADA diagnostic criteria [1,2] from 
the Diabetic Outpatient Department and General Medicine Department 
of Government Medical College and Hospital, Srinagar, India. The 
same number of age- and sex-matched healthy subjects was also 
included in the study who served as controls. The study was approved 
by a Departmental Ethical Committee of Biochemistry, Government 
Medical College, Srinagar. Patients with evidence of acute or chronic 
inflammatory or infectious diseases, cancer, persons on insulin, or 
other medications that could affect glucose metabolism and pregnant 
or lactating women were excluded from the study.
Anthropometric measurements
Height (cm) was noted using a measuring tape to the nearest 0.1 cm. 
Weight (kg) was measured to the nearest 0.1 kg using a weighing 
machine, simultaneously. Body mass index (BMI) was calculated as 
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the ratio of body weight in Kg and height in meter square (kg/m2). 
Participants with a BMI ≥30.0 kg/m2 were considered obese.
Biochemical analysis
Enzyme-linked immunosorbent assay was used to measure serum 
leptin (DRG international, USA; EIA-2395) and TNF-α (Diaclone 
SAS, Besancon Cedex, France) levels as described previously [27]. 
The serum Vitamin D levels were measured by chemiluminescent 
microparticle immunoassay method (Abbot Laboratories Illinois, USA). 
Analysis of serum glucose, glycated hemglobin, cholesterol, low-density 
lipoprotein, high-density lipoprotein, and triglycerides levels was done 
by an enzymatic method (Abbot Laboratories Illinois, USA).
Statistical analysis
All data were expressed as a mean±standard deviation. Data analysis 
was performed using SPSS software for Windows version 16. Group 
means were compared using independent-sample t-test. Correlation 
analysis was performed for determining the relationship between 
serum leptin, TNF-α, and Vitamin D levels and Pearson correlation 
coefficient (r) was obtained. For all assessments, a value of p<0.05 was 
statistically accepted as significant.
RESULTS
Evaluation of basic metabolic parameters
Basic metabolic parameters were measured in T2DM patients and 
control subjects. According to our results, the serum levels of all the 
metabolic parameters were found to be significantly higher in T2DM 
patients as compared to control subjects (Table 1).
Evaluation of serum Vitamin D, TNF-α, and Leptin levels in T2DM 
patients and controls
The serum Vitamin D, TNF-α, and leptin levels were evaluated in T2DM 
patients and control subjects. According to our results, T2DM subjects 
of the study were low in serum Vitamin D levels and high in serum leptin 
and TNF-α levels as compared to controls (p=0.001; Table 1). Further, 
the T2DM females of our study were found to have lower Vitamin D 
levels and higher leptin and TNF-α levels than T2DM males. However, 
Table 1: Basic metabolic parameters, Vitamin D, and adipocytokines measured in cases and controls of the study
Characteristic Cases (n=200) Controls (n=200) p value
Fasting plasma glucose (mg/dl) 176.49±43.3 86.33±12.5 0.001*
HbA1c % 7.4±0.18  5.1±0.05 0.001*
Cholesterol (mg/dl) 179.5±31.8 165±41.8 0.008*
Triglycerides (mg/dl) 192.7±51.2 160±45.5 0.001*
LDL (mg/dl) 119.36±33.29 109.36±32.29 0.0032*
HDL (mg/dl) 30.83±7.67 32.33±6.67 0.14**
BMI (kg/m) 26.5±2.1 22.5±4.2 0.001*
25(OH) D 19.40±10 36.67±7.5 0.001*
Leptin 15.04±7.8 8.17±4.20 0.001*
TNF-α 28.77±14.4 12.55±5.1 0.001*
The data represent mean±SD values of variables of T2DM patients and control subjects (n=200). *p<0.05, **p>0.05 versus controls (independent t-test). HbA1c: 
Glycated hemoglobin, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, BMI: Body mass index, TNF-α: Tumor necrosis factor-alpha, SD: Standard deviation, 
T2DM: Type 2 diabetes mellitus
Table 2: Serum levels of Vitamin D, TNF-alpha, and leptin levels in T2DM male and female patients versus control subjects of the study
Adipokine/mediator Male cases Female cases p valve Male controls Female controls p value
Vitamin D 20.27±10.41 18.52±10.02 0.36** 36.84±7.16 36.50±7.9 0.48**
Leptin 12.66±8.60 17.47±6.30 0.001* 5.69±4.23 10.63±2.26 0.001*
TNF-α 27.53±15.10 30.42±13 0.40** 11.80±5.83 13.22±6.06 0.46**
The data represent mean±SD values for serum Vitamin D, TNF-α, and leptin levels within diabetic cases and control subjects according to gender (n=200). *p<0.05, 
**p>0.05 (Chi-square test). T2DM: Type 2 diabetes mellitus, TNF-α: Tumor necrosis factor-alpha, SD: Standard deviation
Fig. 1: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin levels in type 2 diabetes mellitus subjects. Each 
dot on the scatter plot represents one observation/value (n=200). 
*p<0.05, **p>0.05 (Pearson correlation)
Fig. 2: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin levels in control subjects. Each dot on the 
scatter plot represents one observation/value (n=200). *p<0.05, 
**p>0.05 (Pearson correlation)
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significant gender distribution was found for serum leptin levels only 
(p=0.001; Table 2). The correlation analysis was done between serum 
Vitamin D, TNF-α, and leptin levels and our results concluded that there 
was a non-significant correlation of Vitamin D with leptin (r=−0.071; 
p=0.486) and TNF-α (r=0.103; p=0.309) in T2DM patients and controls 
(r=0.023; p=0.819; r=−0.093; p=0.347; Figs. 1 and 2). However, a positive 
correlation between leptin and TNF-α (r=0.387; p=0.000) was found in 
T2DM subjects as well as in controls (r=0.556; p=0.001; Figs. 1 and 2) 
with significance being higher in females (r=0.500; p=0.001; Fig. 3) as 
compared to males (r=0.298; p=0.036; Fig. 4) in T2DM subjects as well 
as in controls (r=0.659; p=0.001; Fig. 5; r=0.621; p=0001; Fig. 6).
DISCUSSION
T2DM is caused by decreased sensitivity of target tissues to the 
metabolic effects of insulin and is associated with increased plasma 
insulin concentration in the body. It accounts for 90% of all the cases of 
diabetes, and its complications have become a major cause of morbidity 
and mortality worldwide. According to a report from International 
Diabetes Federation, the number of T2DM cases will rise to 552 million 
by 2030 [28,29]. In T2DM patients lipid peroxidation, lipid levels [30] 
and antioxidant levels have been found to be altered [31]. There is 
considerable epidemiological evidence to suggest a role of Vitamin D 
deficiency in the pathogenesis of T2DM and several inflammatory 
biomarkers have also been found to be associated with β-cell failure 
and insulin resistance, both of which are key features of T2DM. Some of 
these immune mediators, such as TNF-α, leptin, and IL-6 may directly 
interfere with insulin signaling, causing insulin resistance through 
several mechanisms [32]. The role of Vitamin D in abnormal glucose 
metabolism as well as in T2DM has been documented [29,16]. Some 
studies have shown an inverse relationship between Vitamin D and 
the incidence of T2DM/insulin resistance [30]. Our results followed a 
pattern of some previous observational studies which demonstrated 
that the risk of diabetes was negatively associated with increased 
Vitamin D concentrations [31] as in the present study, serum Vitamin D 
levels were significantly lower in T2DM patients when compared 
with healthy subjects. The T2DM females of our study were found to 
have low serum Vitamin D levels as compared to T2DM males, but the 
results were statistically insignificant. Therefore, no gender difference 
for serum Vitamin D levels was seen in our cases, and this gender 
difference was not seen in controls as well. Hence, in the present study, 
the high prevalence of hypovitaminosis D in people with T2DM could 
point to an association between the low Vitamin D status and incidence 
of T2DM in our community. Some cross-sectional studies indicated 
Fig. 3: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin levels in type 2 diabetes mellitus female 
subjects. Each dot on the scatter plot represents one observation/
value (n=100). *p<0.05, **p>0.05 (Pearson correlation)
Fig. 4: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin levels in type 2 diabetes mellitus male subjects. 
Each dot on the scatter plot represents one observation/value 
(n=100). *p<0.05, **p>0.05 (Pearson correlation)
Fig. 5: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin in control female subjects. Each dot on the 
scatter plot represents one observation/value (n=100). *p<0.05, 
**p>0.05 (Pearson correlation)
Fig. 6: Correlation between Vitamin D, tumor necrosis factor-
alpha, and leptin levels in control male subjects. Each dot on the 
scatter plot represents one observation/value (n=100). *p<0.05, 
**p>0.05 (Pearson correlation)
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that low Vitamin D levels are associated with higher serum levels of 
inflammatory biomarkers such as IL-6 and TNF-α in healthy [18-21] 
and obese subjects [22] while others could not confirm these 
findings [23-27]. Our results are in accordance with Ganji et al. [23], 
as in our study no significant correlation of Vitamin D levels with 
inflammatory markers TNF-α or leptin was found in T2DM patients 
or controls. However, a positive correlation was observed between 
TNF-α and leptin levels in T2DM patients and controls with correlation 
being stronger among females in both cases and controls. Due to the 
presence of leptin receptors in pancreatic β-cells, there is a strong 
possibility of leptin modulating insulin secretion which several studies 
have also inferred. There are mixed data-driven opinions about the 
association of leptin with T2DM in humans. Several studies did not find 
an association [32,33] while others demonstrated a significant positive 
association between serum leptin levels and T2DM in men [34,35] 
and women [36]. In the present study, serum leptin levels were found 
significantly higher in T2DM patients than normal healthy controls. 
T2DM females of the study were found to have higher serum leptin 
levels than T2DM male subjects which were statistically significant, 
and this gender difference was seen in controls as well. TNF-α is a 
pro-inflammatory mediator and is associated with various diseases 
such as arthritis, sepsis, asthma, and obesity [4,37-39]. TNF-α levels 
are significantly elevated in subjects with T2DM, because of its role in 
lipid metabolism or obesity-associated insulin resistance [40]. A study 
conducted by Miyazaki et al. concluded that TNF-α increases before the 
onset of T2DM and further increase was not associated with insulin 
resistance [8]. However, some studies reported that there is no role of 
TNF-α in the genesis of early stages of insulin resistance [41]. In our 
study, higher TNF-α levels were found in T2DM patients as compared 
to controls. The serum levels of TNF-α were higher in T2DM females 
as compared to T2DM males involved in the study with no statistical 
significance, which implies that there was no gender difference for 
serum TNF-α levels in our cases. Similarly, no gender difference was 
observed in controls as well.
These results concluded that lower Vitamin D levels, and higher leptin, 
and TNF-α levels play a key role in the development of T2DM and from 
the correlation analysis it could be predicted that leptin and TNF-α act 
synergistically toward the development of T2DM.
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